US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

PRME Prime Medicine Inc

7.11

0.17 (2.45%)

24 May 2024 - Cerrado

Retrasado por 15 minutos

Form EFFECT - Notice of Effectiveness

Prime Medicine (NASDAQ:PRME)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Prime Medicine.

Prime Medicine (NASDAQ:PRME)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Prime Medicine.

Noticias sobre Prime Medicine Inc PRME

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Martes 21 de Mayo 2024 (6 días hace) • Edgar (US Regulatory)

Form 8-K - Current report
Martes 21 de Mayo 2024 (6 días hace) • Edgar (US Regulatory)

Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
Lunes 13 de Mayo 2024 (2 semanas hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Viernes 10 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Viernes 10 de Mayo 2024 (2 semanas hace) • Edgar (US Regulatory)

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
Viernes 10 de Mayo 2024 (2 semanas hace) • GlobeNewswire Inc.

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
Miércoles 8 de Mayo 2024 (3 semanas hace) • GlobeNewswire Inc.

Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
Miércoles 1 de Mayo 2024 (4 semanas hace) • GlobeNewswire Inc.

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
Lunes 29 de Abril 2024 (4 semanas hace) • GlobeNewswire Inc.

Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
Martes 23 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Viernes 1 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Viernes 1 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Prime Medicine Inc Artículos de Noticias

Internet Computer

Flow Beverage (QX)

Wasatch LongShort Alpha ...

Leveraged DAX Optimal Pr...

Artemis Alpha Trust

Vanguard ESG Global Corp...

Morgan Stanley Finance L...

Hill and Smith (PK)

Graniteshares 3x Long Vo...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones